ProCE Banner Activity

LA Story: Anticipating Long-Acting HIV Data at IDWeek 2024

Conference Coverage
Clinical Thought

At IDWeek 2024 in Los Angeles, I expect many forms of long-acting ART to steal the show, with important updates on their potential for treatment in multidrug-resistant HIV, for providing new options for uptake and adherence in key populations, and for HIV prevention.  

Released: October 14, 2024

Expiration: October 13, 2025

Share

Faculty

Darcy Wooten

Darcy Wooten, MD, MS

Professor of Medicine
Division of Infectious Diseases
Washington University
St Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Disclosure

Primary Author

Darcy Wooten, MD, MS

Professor of Medicine
Division of Infectious Diseases
Washington University
St Louis, Missouri

Darcy Wooten, MD, MS, has no relevant financial relationships to disclose.